Видео ютуба по тегу Gsk3 Inhibitor

Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight
Webinar: GSK3 Inhibition and Muscle Wasting Disorders: Muscular Dystrophy and Spaceflight
GSK-3 Inhibitors - Treatment of Diabetes and CNS Disorders: Targeting the Substrate Binding Site
GSK-3 Inhibitors - Treatment of Diabetes and CNS Disorders: Targeting the Substrate Binding Site
Novel GSK-3 Inhibitors for Treating CNS Disorders
Novel GSK-3 Inhibitors for Treating CNS Disorders
Elraglusib, a novel small molecule inhibitor of GSK-3
Elraglusib, a novel small molecule inhibitor of GSK-3
The anti-lymphoma effects of the GSK3 inhibitor elraglusib are not attributable to GSK3
The anti-lymphoma effects of the GSK3 inhibitor elraglusib are not attributable to GSK3
Phase II trial of elraglusib, a GSK-3ß inhibitor, in untreated mPDAC
Phase II trial of elraglusib, a GSK-3ß inhibitor, in untreated mPDAC
Lithium's Hypothetical Mechanism of Action
Lithium's Hypothetical Mechanism of Action
IBEC 2022- MHAD 13 Session 1 Val Fajardo, May 25, 2022 (GSK3 Inhibition for conditions of muscle...)
IBEC 2022- MHAD 13 Session 1 Val Fajardo, May 25, 2022 (GSK3 Inhibition for conditions of muscle...)
Enzyme glycogen synthase kinase in carcinogenesis, VIDEO ABSTRACT
Enzyme glycogen synthase kinase in carcinogenesis, VIDEO ABSTRACT
Axonal Autophagy Regulated by GSK3b Phosphorylation of MCL1
Axonal Autophagy Regulated by GSK3b Phosphorylation of MCL1
AACR 2023 highlights in PI3Kα and FGFR inhibition
AACR 2023 highlights in PI3Kα and FGFR inhibition
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 ... | RTCL.TV
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 ... | RTCL.TV
The path from insulin to GSK3 and glycogen synthase
The path from insulin to GSK3 and glycogen synthase
The GSK3 from Moniliophthora roreri: Repurposing... - Décio Lisboa - 3DSIG - Poster - ISMB 2022
The GSK3 from Moniliophthora roreri: Repurposing... - Décio Lisboa - 3DSIG - Poster - ISMB 2022
GSK3β Drives Resistance to Raf Inhibitors in BRAF-Mutant Melanoma | Oncotarget
GSK3β Drives Resistance to Raf Inhibitors in BRAF-Mutant Melanoma | Oncotarget
Glycogen Synthase Regulation
Glycogen Synthase Regulation
Design and Development of a New Series of Kinase Inhibitors
Design and Development of a New Series of Kinase Inhibitors
Phase I/II trial of elraglusib in solid tumors
Phase I/II trial of elraglusib in solid tumors
Insulin Activated Glycogenesis. How Glucose is Stored as Glycogen. PP1 and GSK3 Pathway.
Insulin Activated Glycogenesis. How Glucose is Stored as Glycogen. PP1 and GSK3 Pathway.
A Dual inhibitor (Metavert) of GSK3B and HDACs in Combination With Chemotherapeutics Improve Therapy
A Dual inhibitor (Metavert) of GSK3B and HDACs in Combination With Chemotherapeutics Improve Therapy
Using a genome-wide CRISPR screen to evaluate mechanisms of resistance to FLT3 inhibitors in AML
Using a genome-wide CRISPR screen to evaluate mechanisms of resistance to FLT3 inhibitors in AML
GSK3 and Src autoinhibition mechanism
GSK3 and Src autoinhibition mechanism
Virtual screening of potential kinase inhibitors within the... - Rodrigo Ochoa - Talk - ISCB-LA 2020
Virtual screening of potential kinase inhibitors within the... - Rodrigo Ochoa - Talk - ISCB-LA 2020
Protein Kinase C promotes peroxisome biogenesis and peroxisome-endoplasmic reticulum interaction
Protein Kinase C promotes peroxisome biogenesis and peroxisome-endoplasmic reticulum interaction
Overcoming Chemoresistance and Activating the Immune System in Difficult-to-Treat Cancers
Overcoming Chemoresistance and Activating the Immune System in Difficult-to-Treat Cancers